Latest News for Grifols Stock (OTC:GIKLY)

GRIFOLS SA ADR

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

Short Ideas

Trading Ideas

GIKLY

On Wednesday, shares of Grifols Sa (OTC: GIKLY) experienced volatile short activity. After the activity, the stock price went up +0% to $5.93.

The overall sentiment for GIKLY has been Bearish.

Short Volatility Alert: Grifols Sa

Grifols SA

Grifols, S.A. (GRFS) Q2 2023 Earnings Call Transcript

Grifols, S.A. (GRFS) Q3 2023 Earnings Call Transcript

Grifols said to be in talks for a partial sale of Shanghai RAAS

Grifols Is Building Momentum

Doubling Down On Gain Therapeutics

Grifols shares plunge after report on debt ratio concerns

Grifols: Wait And See For Now

Grifols' banking exposure under ECB scrutiny: Reuters

Grifols appoints new CEO; founding family members to leave executive roles

Grifols: Q4 Was Positive, Still Too Many Question Marks

BAYRY

BAYZF

BBVA

BNPQF

BNPQY

CAIXY

CIXPF

DNPUF

EXAI

GANX

GIFLF

GIFOF

GRFS

OCPNF

OLYMY

RXRX

SMDPY

SRPT

VRTX

ZNTL

Press Releases

ROSEN, A LEADING NATIONAL FIRM, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF

Small Cap

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF

ROSEN, A LEADING LAW FIRM, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF

News

Legal

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF

ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF

Johnson Fistel, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF

Grifols

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Grifols Stock (OTC:GIKLY)

Thursday, December 08, 2022